Regulatory PathRegulatory requirements compared

Active substance

Cyclizine

Open in the medicines table

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
MAREZINE50MG/MLinjectable · injectionGLAXOSMITHKLINEDiscontinued24 Sep 1954

UK MHRA United Kingdom — marketing authorisations

ProductAuthorisationHolderLegal status
CYCLIZINE HYDROCHLORIDE 50 MG TABLETSPL 20072/0241AMDIPHARM UK LIMITEDP
CYCLIZINE HYDROCHLORIDE 50 MG TABLETSPL 25298/0046BROWN & BURK UK LIMITEDP
CYCLIZINE HYDROCHLORIDE 50MG TABLETSPL 15764/0135STRANDHAVEN LIMITEDP
CYCLIZINE HYDROCHLORIDE 50MG TABLETSPL 20117/0216MORNINGSIDE HEALTHCARE LIMITEDP
CYCLIZINE LACTATE 50 MG/ ML SOLUTION FOR INJECTIONPL 25298/0314BROWN & BURK UK LIMITEDPOM
CYCLIZINE LACTATE 50 MG/ML INJECTIONPL 20072/0010AMDIPHARM UK LIMITEDPOM
CYCLIZINE LACTATE 50 MG/ML INJECTIONPL 20117/0314MORNINGSIDE HEALTHCARE LIMITEDPOM
CYCLIZINE LACTATE 50 MG/ML SOLUTION FOR INJECTIONPL 01502/0104HAMELN PHARMA LTDPOM
CYCLIZINE LACTATE 50 MG/ML SOLUTION FOR INJECTIONPL 01883/0270MACARTHYS LABORATORIES LIMITEDPOM
CYCLIZINE LACTATE 50 MG/ML SOLUTION FOR INJECTIONPL 39280/0012SYNCHRONY PHARMA LIMITEDPOM
CYCLIZINE LACTATE 50 MG/ML SOLUTION FOR INJECTIONPL 56854/0020ORBIT PHARMA LIMITEDPOM
CYCLIZINE LACTATE 50MG/ML INJECTIONPL 35104/0021PHOENIX LABS UNLIMITED COMPANYPOM
CYCLIZINE LACTATE 50MG/ML SOLUTION FOR INJECTIONPL 15764/0209STRANDHAVEN LIMITEDPOM
VALOID 50MG TABLETSPL 20072/0241AMDIPHARM UK LIMITEDP
VALOID INJECTIONPL 20072/0010AMDIPHARM UK LIMITEDPOM

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
NHS Drug TariffCyclizine 50mg tablets£3.09100 tablet1 Oct 2026
NHS Drug TariffCyclizine 50mg/1ml solution for injection ampoules£3.245 ampoule1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

WHO WHO Model List of Essential Medicines (2025)

  • 2.3. Medicines for other common symptoms in palliative care · core
    Palliative care
    Parenteral > General injections > unspecified: 50 mg per mL (lactate) (EMLc) | Oral > Solid > tablet: 50 mg (hydrochloride) (EMLc)

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.